PATRICIA GOLDSMITH was named CEO of CancerCare.
Goldsmith previously served as executive vice president and chief operating officer at the National Comprehensive Cancer Network, where she was responsible for overall operations and provided oversight for national programs and initiatives. She will take the job May 5.
Prior to joining NCCN, she was vice president for institutional development and public affairs and marketing at the H. Lee Moffitt Cancer Center & Research Institute.
By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it. To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...
As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease. The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...
